Site Search
Results
-
Minutes: BSC; April 17-18, 2014
... He added that the issue of polypharmacy must be considered, particularly in the case of cancer patients who may be using the substance as an adjunct to other therapies. Dr. Walker ...
Size: 253KB https://ntp.niehs.nih.gov/sites/default/files/ntp/about_ntp/bsc/2014/april/minutes20140418_508.pdf -
Summary Minutes December 7-8, 2017 NTP Board of Scientific Counselors
... The program itself began in 2012, with a goal to develop an in vitro platform that uses human tissues to evaluate the efficacy, safety, and toxicity of promising therapies. The ...
Size: 352KB https://ntp.niehs.nih.gov/sites/default/files/ntp/about_ntp/bsc/2017/december/minutes20171208_508.pdf -
RoC Profile: Aristolochic Acids; 15th RoC 2021
... In contemporary medicine, Aristolochia plant extracts have been used in therapies for arthritis, gout, rheu- matism, and festering wounds, but these uses were discontinued in ...
Size: 182KB https://ntp.niehs.nih.gov/sites/default/files/ntp/roc/content/profiles/aristolochicacids.pdf -
Nomination of MAT Test for Pyrogen Detection (April 2011)
... applicable to multiple agencies or programs Pyrogen testing is a crucial safety requirement for injectable drugs , eye drops , medical devices , cell therapies , baby food etc. ...
Size: 1.4MB https://ntp.niehs.nih.gov/iccvam/methods/pyrogen/mat-2011/iccvamnom-pyrodetecthk290311f-508.pdf -
Research Concept: Viruses; 2014
... At Risk Populations enveloped decreased t o 0 .63% (2010) with anti--- retroviral therapies e Merkel cell f virus (MCV) Polyoma virus Double---stranded DNA virus, non--- ...
Size: 331KB https://ntp.niehs.nih.gov/ntp/roc/concept_docs/2014/virusesconcept_508.pdf -
ICCVAM PF 2023 _230511_JM EB
... National Cancer Institute CAR-T cell therapies are ground-breaking, life-saving ... methods to evaluate the safety of these therapies, that have extraordinarily high risk for ...
Size: 191KB https://ntp.niehs.nih.gov/iccvam/meetings/iccvam-forum-2023/pubcmts/pcrm20230512_508.pdf -
Assay Application
... alternating current or direct current therapies that use electrical stimulation to ... to determine the impact of low current stimulation, emulating transcranial therapies. ...
https://ntp.niehs.nih.gov/iccvamreport/2023/confidence/assay -
Assay Development
... EPA Endocrine Disruptors NIEHS Safety testing strategy for cell-based human cancer therapies Preclinical safety assessment for CAR T cell-based therapies is necessary because ...
https://ntp.niehs.nih.gov/iccvamreport/2023/technology/assay-dev -
RoC Monograph: Helicobacter pylori (Chronic Infection); October...
... Many different therapies are used in the United States, but the American College of ... OR intervention*[tiab] OR therapies[tiab] OR Therapy[tiab] OR ...
Size: 993KB https://ntp.niehs.nih.gov/ntp/roc/monographs/hpylori_final20181026_508.pdf -
Final Minutes: 2024 SACATM Meeting
... Three key areas of activity are: . Accelerating prevention efforts, new therapies, diagnostics, and potential cures. . Advancing global health and equity in care. . Training the ...
Size: 517KB https://ntp.niehs.nih.gov/sites/default/files/2024-12/2024_SACATM_minutes_final_508.pdf
to Top